(Reuters) –     Pfizer has named company veteran Chris Boshoff, who led the drugmaker’s cancer research and marketing for more than a year, as its R&D chief, WSJ reported on Wednesday.  (Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini Ganguli)

WTVB

Pfizer names Chris Boshoff as new R&D chief, WSJ reports

Pfizer said it has named Chris Boshoff, who led the drugmaker's cancer research and marketing for more than a year, as its chief of research and development.

Ad Fontes Media

All Sides

Media Bias/Fact Check

CNBC

Roberts family

United States

Pfizer names insider Chris Boshoff as R&D chief

Midwest Communications

Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief scientific officer starting Jan. 1. Article Attribution | Read More at Article Source The post Pfizer Names New R&D Chief appeared first on RocketNews.

RocketNews

Pfizer Names New R&D Chief

Chris Boshoff will become Pfizer's chief scientific officer and R&D president on January 1, replacing Mikael Dolsten. Roger Dansey will temporarily fill Boshoff's previous role as chief oncology officer, and Johanna Bendell will join from Roche as chief development officer for oncology.

Endpoints News

Pfizer taps oncology head Boshoff as Dolsten's chief scientific officer successor

biopharmadive.com

Pfizer, under pressure to change, names oncology head as new R&D chief

Dr. Chris Boshoff will oversee all functions of Research & Development across all therapeutic areas.

Pfizer names Chris Boshoff as new R&D chief, WSJ reports

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics